Lipocomb 10 mg / 10 mg Capsules – 30 Capsules
Lipocomb 10/10 mg is a combination lipid-lowering medication used to manage high cholesterol and triglyceride levels. It contains Rosuvastatin and Ezetimibe, offering a dual-action approach to reduce cholesterol production in the liver and limit its absorption from the intestine. Lipocomb is commonly prescribed for patients with dyslipidemia who require more intensive lipid control.
Active Ingredient and Composition
-
Active Ingredients:
-
Rosuvastatin 10 mg
-
Ezetimibe 10 mg
-
-
Dosage Form: Film-coated tablets
-
Pack Size: 30 tablets
Drug Class
-
Pharmacological Class: Statin + Cholesterol Absorption Inhibitor
-
Therapeutic Category: Antihyperlipidemic agents
Uses and Medical Indications of Lipocomb
Lipocomb 10/10 mg is indicated for:
-
Hypercholesterolemia (high LDL cholesterol)
-
Mixed dyslipidemia (elevated cholesterol and triglycerides)
-
Reduction of cardiovascular risk, including atherosclerosis and heart disease
-
Lowering total cholesterol and triglycerides
It is used alongside dietary and lifestyle modifications.
How Lipocomb Works
Lipocomb provides a dual lipid-lowering mechanism:
-
Rosuvastatin: Inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver
-
Ezetimibe: Blocks intestinal absorption of cholesterol
This combination effectively lowers LDL cholesterol, total cholesterol, and triglycerides, while supporting overall cardiovascular health.
Dosage and Administration of Lipocomb
-
Recommended dose: One tablet once daily
-
Taken orally with or without food
-
Swallow the tablet whole; do not crush or chew
Important:
-
Follow your doctor’s instructions regarding diet and dosage
Possible Side Effects of Lipocomb
Common side effects may include:
-
Headache
-
Dizziness
-
Constipation or diarrhea
-
Muscle pain (myalgia)
-
Abdominal discomfort
Less common:
-
General fatigue or weakness
-
Elevated liver enzymes (requires monitoring)
Contraindications
Do not use Lipocomb if you have:
-
Active liver disease
-
Severe kidney impairment (unless supervised)
-
Hypersensitivity to rosuvastatin or ezetimibe
-
Pregnancy or breastfeeding
Drug Interactions
Lipocomb may interact with:
-
Other lipid-lowering drugs (increased risk of muscle toxicity)
-
Anticoagulants (monitor clotting parameters)
-
Certain antibiotics or antifungals
Warnings and Precautions
-
Monitor liver function tests regularly
-
Report unexplained muscle pain or weakness
-
Use cautiously in patients with kidney or liver impairment
-
Maintain a cholesterol-lowering diet
Use During Pregnancy and Breastfeeding
-
Contraindicated during pregnancy
-
Not recommended during breastfeeding
Use for Children
-
Use only under specialist supervision
Drug Alternatives
Alternative therapies include:
-
Rosuvastatin alone
-
Ezetimibe alone
-
Other statins (e.g., atorvastatin)
-
PCSK9 inhibitors (for resistant cases)
Comparison With Similar Drugs
Compared with statin monotherapy:
-
Lipocomb offers greater LDL reduction
-
Targets both cholesterol synthesis and absorption
-
Suitable for patients not achieving goals with single therapy
Safe Usage Tips
-
Follow a low-fat, heart-healthy diet
-
Exercise regularly
-
Avoid excessive alcohol consumption
-
Take medication consistently at the same time daily
-
Monitor lipid levels regularly
Frequently Asked Questions (FAQ)
How do I know if my cholesterol has improved?
Through regular blood tests measuring cholesterol and triglyceride levels.
Why can cholesterol drop suddenly?
It is rare but may be linked to underlying conditions or metabolic changes.
Can Lipocomb be used alone without diet changes?
No, it should always be combined with a healthy lifestyle for best results.
Is Lipocomb safe for long-term use?
Yes, under medical supervision with regular monitoring.
Conclusion
Lipocomb 10/10 mg is an effective combination therapy for managing high cholesterol and triglycerides. With its dual mechanism, Lipocomb helps improve lipid profiles and reduce cardiovascular risk when used alongside a healthy lifestyle.
| Offer Label | Need Physician Approval |
|---|---|
| Shipping Type | Express |